Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant.
Wu, Xiao; Kwong, Allison; Heller, Michael; Lokken, R Peter; Fidelman, Nicholas; Mehta, Neil.
Affiliation
  • Wu X; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA.
  • Kwong A; Department of Gastroenterology & Hepatology, Stanford University, Stanford, California, USA.
  • Heller M; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA.
  • Lokken RP; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA.
  • Fidelman N; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA.
  • Mehta N; Department of General Hepatology and Liver Transplantation, University of California, San Francisco, California, USA.
Liver Transpl ; 30(2): 151-159, 2024 02 01.
Article in En | MEDLINE | ID: mdl-37639286

Full text: 1 Database: MEDLINE Main subject: Liver Transplantation / Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Liver Transpl Journal subject: GASTROENTEROLOGIA / TRANSPLANTE Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Liver Transplantation / Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Liver Transpl Journal subject: GASTROENTEROLOGIA / TRANSPLANTE Year: 2024 Type: Article Affiliation country: United States